Search

everythinglearnresearchcommunity

for

Search:↓

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Certain immune responses may cause ongoing COVID-19 symptoms like fatigue and brain fog.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Replenishing iron after phlebotomy can cause relapse in porphyria cutanea tarda.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

T cells with memory features grow in number and gather around hair follicles when there are not enough immune cells.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Clinicians should be aware of alternating thyroid conditions and their treatment.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Tick bites can cause temporary hair loss similar to alopecia areata in some people.

A woman experienced severe symptoms, including hair loss, after a COVID-19 vaccine, suggesting a possible autoimmune reaction.

Diphencyprone treatment for alopecia areata can cause vitiligo in some patients.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Early diagnosis and treatment of TPP can prevent complications.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Lowering the dose of cyclosporin caused hair loss that didn't improve even when the dose was increased again.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Tph cells are linked to the severity of systemic lupus erythematosus.

A three-year-old girl survived a rare serious infection caused by BCG vaccination, which improved after treatment with a leprosy drug.